
ADAM17 - Wikipedia
A disintegrin and metalloprotease 17 (ADAM17), also called TACE (tumor necrosis factor-α-converting enzyme), is a 70-kDa enzyme that belongs to the ADAM protein family of disintegrins and metalloproteases, activated by substrate presentation.
Strategies to Target ADAM17 in Disease: From Its Discovery to …
ADAM17 plays a key role in activating IL-6 trans-signaling pathway, as it sheds the ectodomain of IL-6R, both in vitro and in vivo [27,28]. Soluble IL-6R (sIL-6R) retains its ability to bind IL-6, preventing it from binding to the membrane-tethered form of the receptor.
Updates on Inflammatory Molecular Pathways Mediated by ADAM17 …
Nov 13, 2024 · The functional ADAM17 is involved in the shedding of the ectodomain characterizing many substrates belonging to growth factors, cytokines, receptors, and adhesion molecules. The ADAM17-dependent pathways are known to be crucial in tumor development and progression and in the modulation of many pathological and physiological processes.
Control of ADAM17 activity by regulation of its cellular ... - Nature
Oct 12, 2016 · ADAM17 is mainly endocytosed via a clathrin-dependent pathway. Which endocytic pathway is responsible for ADAM17 internalisation?
ADAM 17 and Epithelial-to-Mesenchymal Transition: The Evolving …
This review provides an overview of the role of ADAM17 in EMT-associated pathways, highlighting new therapeutic perspectives on fibrotic diseases and cancer. As this review underlines, several studies on ADAM17 structure and function in …
The protease ADAM17 at the crossroads of disease: revisiting its ...
Aug 4, 2023 · ADAM17 is involved in the cleavage and shedding of at least 80 known membrane-tethered proteins, which subsequently modulate several intracellular signaling pathways, and therefore alter cell behavior.
Recent Advances in ADAM17 Research: A Promising Target for …
Knowledge of the substrates of ADAM17 helped provide a pathway as to what would be the best use of an ADAM17 inhibitor in the clinic. Researchers have now developed selective inhibitors after learning early on of the failures of small molecules that also targeted the matrix metalloproteinase family [ 13 – 15 ].
ADAM17: a molecular switch to control inflammation and tissue ...
Aug 1, 2011 · Activated ADAM17 is capable of controlling pathways that are biologically distinct. On one hand, cleavage of substrates, including TNFα, IL-6R and L-selectin, can be considered pro-inflammatory because they stimulate both innate and acquired immune responses ( Figure 3 ).
Strategies to Target ADAM17 in Disease: From Its Discovery to
Feb 10, 2021 · Neuron-associated ADAM17 may have a beneficial effect by triggering the non-amyloidogenic pathway of APP processing, while microglia-associated ADAM17 can be detrimental for its ability to release TNF and sustain chronic inflammatory responses.
Updates on Inflammatory Molecular Pathways Mediated by ADAM17 …
Dec 18, 2024 · The functional ADAM17 is involved in the shedding of the ectodomain characterizing many substrates belonging to growth factors, cytokines, receptors, and adhesion molecules. The ADAM17-dependent pathways are known to be crucial in tumor development and progression and in the modulation of many pathological and physiological processes.